BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

  January 12, 2026

   · 

  6 min read
• Press Releases

  Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

  January 12, 2026

   · 

  7 min read
• Press Releases

  Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference

  January 12, 2026

   · 

  1 min read
• Press Releases

  SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39

  January 12, 2026

   · 

  3 min read
• Press Releases

  KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease

  January 12, 2026

   · 

  3 min read
• Press Releases

  Diorasis Therapeutics Appoints Richard A. Kresch, MD, to Board of Directors

  January 12, 2026

   · 

  2 min read
• Press Releases

  Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals

  January 12, 2026

   · 

  2 min read
• Press Releases

  PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

  January 12, 2026

   · 

  4 min read
• 

  Venture capital

  Early-Stage Biotechs Feel the Squeeze as Funding Favors Derisked Assets: JPM

  Heightened diligence standards and longer decision timelines for early-stage startups slowed venture activity last year, J.P. Morgan found in a report published ahead of the bank’s annual healthcare conference in San Francisco.

  January 12, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  PromiCell, Inc. presents during JP Morgan’s 2026 Healthcare Conference

  January 12, 2026

   · 

  1 min read